Deep Brain Stimulation in Parkinson’s Disease
A Global Strategic Business Report
MCP30395
WHAT'S BEHIND OUR DATA?
140857226
DOMAIN TRANSCRIPTS6080276
BRANDS TRACKED1729341
FEATURED COMPANIES22574
TOPICS COVERED82719
MARKET SEGMENTS91
KEY INDUSTRIES1574
CURATION TEAM4761909
DECISION MAKERSEXECUTIVE ENGAGEMENTS BY TIER (55)
3
CXO5
VICE PRESIDENT10
DIRECTOR25
MANAGER12
MARKETINGHIGHLIGHTS & REPORT INDEX
Global Deep Brain Stimulation in Parkinson’s Disease Market to Reach US$1.5 Billion by 2030
The global market for Deep Brain Stimulation in Parkinson’s Disease estimated at US$882.5 Million in the year 2024, is expected to reach US$1.5 Billion by 2030, growing at a CAGR of 8.7% over the analysis period 2024-2030. Dual-Channel Deep Brain Stimulation, one of the segments analyzed in the report, is expected to record a 10.2% CAGR and reach US$953.8 Million by the end of the analysis period. Growth in the Single-Channel Deep Brain Stimulation segment is estimated at 6.2% CAGR over the analysis period.
The U.S. Market is Estimated at US$240.4 Million While China is Forecast to Grow at 13.8% CAGR
The Deep Brain Stimulation in Parkinson’s Disease market in the U.S. is estimated at US$240.4 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$322.2 Million by the year 2030 trailing a CAGR of 13.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.3% and 8.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.8% CAGR.
Global Deep Brain Stimulation in Parkinson’s Disease Market – Key Trends & Drivers Summarized
Is Deep Brain Stimulation the Future of Parkinson’s Disease Treatment?
Deep Brain Stimulation (DBS) has emerged as a groundbreaking treatment for Parkinson’s disease, offering new hope to patients experiencing motor fluctuations and medication-resistant symptoms. This neurosurgical procedure involves implanting electrodes into specific brain regions, delivering controlled electrical impulses to modulate abnormal neural activity. Over the years, DBS technology has significantly evolved, with newer, more precise systems improving patient outcomes. Traditional pharmacological treatments for Parkinson’s disease, such as levodopa, often become less effective over time, leading to debilitating motor complications. DBS provides a long-term solution, reducing tremors, rigidity, and dyskinesia, thereby improving quality of life. The rise in minimally invasive surgical techniques and real-time neuroimaging has enhanced the safety and accuracy of DBS procedures. Additionally, research into adaptive DBS, which adjusts stimulation levels dynamically based on brain activity, is opening new doors for personalized treatment strategies.
How Are Technological Advancements Enhancing Deep Brain Stimulation?
Advancements in DBS technology have dramatically improved precision, safety, and patient comfort. The introduction of rechargeable and MRI-compatible implants has increased the longevity of devices, reducing the need for frequent replacements. Closed-loop DBS systems, which adjust stimulation parameters in real time based on neural feedback, are revolutionizing the field by providing more tailored and efficient treatment. Furthermore, AI and machine learning are being integrated into DBS programming, allowing physicians to optimize stimulation settings with unprecedented accuracy. The emergence of wireless programming and remote monitoring capabilities is also making post-surgical management more efficient, enabling neurologists to track patient progress without requiring frequent hospital visits. These advancements are not only enhancing clinical outcomes but also expanding the accessibility of DBS to a broader patient base.
What Is Driving the Growing Adoption of DBS in Parkinson’s Patients?
The increasing prevalence of Parkinson’s disease, coupled with an aging global population, is driving the demand for advanced treatment options like DBS. As more clinical trials validate the long-term efficacy and safety of DBS, physicians are recommending the procedure earlier in disease progression rather than as a last-resort treatment. The growing awareness among patients about non-pharmacological interventions has also contributed to higher adoption rates. Additionally, improvements in surgical robotics and electrode placement techniques have reduced the risks associated with the procedure, making it a more viable option for a wider range of patients. Governments and healthcare organizations are also recognizing the benefits of DBS, leading to increased insurance coverage and reimbursement policies that make the treatment more financially accessible.
The Growth in the Deep Brain Stimulation in Parkinson’s Disease Market Is Driven by Several Factors…
The growth in the DBS market is driven by several factors, including rapid technological advancements, the rising incidence of Parkinson’s disease, and an increasing preference for non-invasive, long-term treatment solutions. The development of AI-driven and closed-loop stimulation systems is enhancing treatment precision, making DBS more effective for a broader range of patients. The expansion of neurology-focused healthcare infrastructure and increasing investments in neurotechnology research are also playing a crucial role in market expansion. Furthermore, the rising number of regulatory approvals and favorable reimbursement policies are encouraging more hospitals and clinics to adopt DBS as a standard Parkinson’s treatment. The push toward personalized medicine, where stimulation parameters are adjusted based on patient-specific needs, is another major driver propelling the market forward.
SCOPE OF STUDY
The report analyzes the Deep Brain Stimulation in Parkinson’s Disease market by the following Segments, and Geographic Regions/Countries:
Segments:
Product (Dual-Channel Deep Brain Stimulation, Single-Channel Deep Brain Stimulation); End-Use (Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use, Research Centers End-Use).
Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa..
SELECT PLAYERS
Abbott Laboratories; Aleva Neurotherapeutics SA; Beijing Pinchi Medical Equipment Co., Ltd.; Beijing PINS Medical Co., Ltd.; Boston Scientific; BrainsWay Ltd.; DBS Technologies Pty Ltd; Epi-Minder; Fisher Wallace Laboratories; Flow Neuroscience; Functional Neuromodulation Ltd.; InBrain Neuroelectronics; Integer Holdings Corporation; LivaNova PLC; Medtronic; Neo-Bionica; Neuroelectrics; NeuroPace, Inc.; Pulsetto; Renishaw PLC
AI INTEGRATIONS
We’re transforming market and competitive intelligence with validated expert content and AI tools.
Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.
TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.
TABLE OF CONTENTS
| I. METHODOLOGY |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy |
| How Trump’s Tariffs Impact the Market? The Big Question on Everyone’s Mind |
| Deep Brain Stimulation in Parkinson’s Disease – Global Key Competitors Percentage Market Share in 2025 (E) |
| Competitive Market Presence - Strong/Active/Niche/Trivial for 37 Players Worldwide in 2025 (E) |
| 2. FOCUS ON SELECT PLAYERS |
| 3. MARKET TRENDS & DRIVERS |
| Rising Prevalence of Parkinson`s Disease Throws the Spotlight on Advanced Neuromodulation Therapies |
| Growing Patient Eligibility and Early Diagnosis Spur Demand for Deep Brain Stimulation (DBS) Interventions |
| Technological Advancements in Directional Leads and Closed-Loop Systems Strengthen the Business Case for DBS |
| Improved Battery Life and Rechargeable Implant Systems Enhance Patient Compliance and Quality of Life |
| Increasing Neurologist Awareness and Surgical Training Expand Accessibility to DBS Across Care Settings |
| FDA and CE Approvals of Next-Generation Devices Accelerate Market Penetration in Key Regions |
| Growing Evidence Base for DBS in Non-Motor Symptoms Propels Broader Use Across PD Patient Segments |
| Insurance Reimbursement and Coverage Expansion Support Affordability in Advanced Parkinson`s Care |
| Adoption of MRI-Compatible Devices Reduces Risk and Facilitates Post-Surgical Monitoring |
| Wearable and App-Based Patient Tracking Tools Integrate with DBS Systems for Outcome Optimization |
| Minimally Invasive Surgical Techniques Reduce Recovery Time and Improve Patient Uptake |
| DBS Research in Younger-Onset Parkinson`s and Genetic Cases Opens New Treatment Frontiers |
| Public-Private Research Initiatives Drive Investment and Innovation in Neuromodulation Platforms |
| Growing Global Burden of Neurological Disorders Supports Long-Term Growth in DBS Infrastructure |
| 4. GLOBAL MARKET PERSPECTIVE |
| World Deep Brain Stimulation in Parkinson’s Disease Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030 |
| World Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson’s Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR |
| World Historic Review for Deep Brain Stimulation in Parkinson’s Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Deep Brain Stimulation in Parkinson’s Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Dual-Channel Deep Brain Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR |
| World Historic Review for Dual-Channel Deep Brain Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Dual-Channel Deep Brain Stimulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Single-Channel Deep Brain Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR |
| World Historic Review for Single-Channel Deep Brain Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Single-Channel Deep Brain Stimulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR |
| World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Ambulatory Surgical Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR |
| World Historic Review for Ambulatory Surgical Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Ambulatory Surgical Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Neurology Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR |
| World Historic Review for Neurology Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Neurology Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Research Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR |
| World Historic Review for Research Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Research Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030 |
| III. MARKET ANALYSIS |
| UNITED STATES |
| Deep Brain Stimulation in Parkinson’s Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E) |
| USA Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson’s Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| USA Historic Review for Deep Brain Stimulation in Parkinson’s Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| USA 15-Year Perspective for Deep Brain Stimulation in Parkinson’s Disease by Product - Percentage Breakdown of Value Sales for Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation for the Years 2015, 2025 & 2030 |
| USA Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson’s Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| USA Historic Review for Deep Brain Stimulation in Parkinson’s Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| USA 15-Year Perspective for Deep Brain Stimulation in Parkinson’s Disease by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use for the Years 2015, 2025 & 2030 |
| CANADA |
| Canada Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson’s Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Canada Historic Review for Deep Brain Stimulation in Parkinson’s Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Canada 15-Year Perspective for Deep Brain Stimulation in Parkinson’s Disease by Product - Percentage Breakdown of Value Sales for Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation for the Years 2015, 2025 & 2030 |
| Canada Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson’s Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Canada Historic Review for Deep Brain Stimulation in Parkinson’s Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Canada 15-Year Perspective for Deep Brain Stimulation in Parkinson’s Disease by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use for the Years 2015, 2025 & 2030 |
| JAPAN |
| Deep Brain Stimulation in Parkinson’s Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E) |
| Japan Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson’s Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Japan Historic Review for Deep Brain Stimulation in Parkinson’s Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Japan 15-Year Perspective for Deep Brain Stimulation in Parkinson’s Disease by Product - Percentage Breakdown of Value Sales for Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation for the Years 2015, 2025 & 2030 |
| Japan Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson’s Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Japan Historic Review for Deep Brain Stimulation in Parkinson’s Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Japan 15-Year Perspective for Deep Brain Stimulation in Parkinson’s Disease by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use for the Years 2015, 2025 & 2030 |
| CHINA |
| Deep Brain Stimulation in Parkinson’s Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E) |
| China Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson’s Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| China Historic Review for Deep Brain Stimulation in Parkinson’s Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| China 15-Year Perspective for Deep Brain Stimulation in Parkinson’s Disease by Product - Percentage Breakdown of Value Sales for Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation for the Years 2015, 2025 & 2030 |
| China Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson’s Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| China Historic Review for Deep Brain Stimulation in Parkinson’s Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| China 15-Year Perspective for Deep Brain Stimulation in Parkinson’s Disease by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use for the Years 2015, 2025 & 2030 |
| EUROPE |
| Deep Brain Stimulation in Parkinson’s Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E) |
| Europe Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson’s Disease by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR |
| Europe Historic Review for Deep Brain Stimulation in Parkinson’s Disease by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Europe 15-Year Perspective for Deep Brain Stimulation in Parkinson’s Disease by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030 |
| Europe Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson’s Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Europe Historic Review for Deep Brain Stimulation in Parkinson’s Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Europe 15-Year Perspective for Deep Brain Stimulation in Parkinson’s Disease by Product - Percentage Breakdown of Value Sales for Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation for the Years 2015, 2025 & 2030 |
| Europe Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson’s Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Europe Historic Review for Deep Brain Stimulation in Parkinson’s Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Europe 15-Year Perspective for Deep Brain Stimulation in Parkinson’s Disease by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use for the Years 2015, 2025 & 2030 |
| FRANCE |
| Deep Brain Stimulation in Parkinson’s Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E) |
| France Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson’s Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| France Historic Review for Deep Brain Stimulation in Parkinson’s Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| France 15-Year Perspective for Deep Brain Stimulation in Parkinson’s Disease by Product - Percentage Breakdown of Value Sales for Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation for the Years 2015, 2025 & 2030 |
| France Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson’s Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| France Historic Review for Deep Brain Stimulation in Parkinson’s Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| France 15-Year Perspective for Deep Brain Stimulation in Parkinson’s Disease by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use for the Years 2015, 2025 & 2030 |
| GERMANY |
| Deep Brain Stimulation in Parkinson’s Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E) |
| Germany Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson’s Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Germany Historic Review for Deep Brain Stimulation in Parkinson’s Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Germany 15-Year Perspective for Deep Brain Stimulation in Parkinson’s Disease by Product - Percentage Breakdown of Value Sales for Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation for the Years 2015, 2025 & 2030 |
| Germany Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson’s Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Germany Historic Review for Deep Brain Stimulation in Parkinson’s Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Germany 15-Year Perspective for Deep Brain Stimulation in Parkinson’s Disease by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use for the Years 2015, 2025 & 2030 |
| ITALY |
| Italy Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson’s Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Italy Historic Review for Deep Brain Stimulation in Parkinson’s Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Italy 15-Year Perspective for Deep Brain Stimulation in Parkinson’s Disease by Product - Percentage Breakdown of Value Sales for Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation for the Years 2015, 2025 & 2030 |
| Italy Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson’s Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Italy Historic Review for Deep Brain Stimulation in Parkinson’s Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Italy 15-Year Perspective for Deep Brain Stimulation in Parkinson’s Disease by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use for the Years 2015, 2025 & 2030 |
| UNITED KINGDOM |
| Deep Brain Stimulation in Parkinson’s Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E) |
| UK Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson’s Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| UK Historic Review for Deep Brain Stimulation in Parkinson’s Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| UK 15-Year Perspective for Deep Brain Stimulation in Parkinson’s Disease by Product - Percentage Breakdown of Value Sales for Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation for the Years 2015, 2025 & 2030 |
| UK Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson’s Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| UK Historic Review for Deep Brain Stimulation in Parkinson’s Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| UK 15-Year Perspective for Deep Brain Stimulation in Parkinson’s Disease by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use for the Years 2015, 2025 & 2030 |
| SPAIN |
| Spain Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson’s Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Spain Historic Review for Deep Brain Stimulation in Parkinson’s Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Spain 15-Year Perspective for Deep Brain Stimulation in Parkinson’s Disease by Product - Percentage Breakdown of Value Sales for Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation for the Years 2015, 2025 & 2030 |
| Spain Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson’s Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Spain Historic Review for Deep Brain Stimulation in Parkinson’s Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Spain 15-Year Perspective for Deep Brain Stimulation in Parkinson’s Disease by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use for the Years 2015, 2025 & 2030 |
| RUSSIA |
| Russia Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson’s Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Russia Historic Review for Deep Brain Stimulation in Parkinson’s Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Russia 15-Year Perspective for Deep Brain Stimulation in Parkinson’s Disease by Product - Percentage Breakdown of Value Sales for Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation for the Years 2015, 2025 & 2030 |
| Russia Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson’s Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Russia Historic Review for Deep Brain Stimulation in Parkinson’s Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Russia 15-Year Perspective for Deep Brain Stimulation in Parkinson’s Disease by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use for the Years 2015, 2025 & 2030 |
| REST OF EUROPE |
| Rest of Europe Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson’s Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Rest of Europe Historic Review for Deep Brain Stimulation in Parkinson’s Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Rest of Europe 15-Year Perspective for Deep Brain Stimulation in Parkinson’s Disease by Product - Percentage Breakdown of Value Sales for Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation for the Years 2015, 2025 & 2030 |
| Rest of Europe Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson’s Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Rest of Europe Historic Review for Deep Brain Stimulation in Parkinson’s Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Rest of Europe 15-Year Perspective for Deep Brain Stimulation in Parkinson’s Disease by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use for the Years 2015, 2025 & 2030 |
| ASIA-PACIFIC |
| Deep Brain Stimulation in Parkinson’s Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E) |
| Asia-Pacific Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson’s Disease by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR |
| Asia-Pacific Historic Review for Deep Brain Stimulation in Parkinson’s Disease by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Asia-Pacific 15-Year Perspective for Deep Brain Stimulation in Parkinson’s Disease by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030 |
| Asia-Pacific Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson’s Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Asia-Pacific Historic Review for Deep Brain Stimulation in Parkinson’s Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Asia-Pacific 15-Year Perspective for Deep Brain Stimulation in Parkinson’s Disease by Product - Percentage Breakdown of Value Sales for Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation for the Years 2015, 2025 & 2030 |
| Asia-Pacific Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson’s Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Asia-Pacific Historic Review for Deep Brain Stimulation in Parkinson’s Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Asia-Pacific 15-Year Perspective for Deep Brain Stimulation in Parkinson’s Disease by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use for the Years 2015, 2025 & 2030 |
| AUSTRALIA |
| Deep Brain Stimulation in Parkinson’s Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E) |
| Australia Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson’s Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Australia Historic Review for Deep Brain Stimulation in Parkinson’s Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Australia 15-Year Perspective for Deep Brain Stimulation in Parkinson’s Disease by Product - Percentage Breakdown of Value Sales for Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation for the Years 2015, 2025 & 2030 |
| Australia Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson’s Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Australia Historic Review for Deep Brain Stimulation in Parkinson’s Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Australia 15-Year Perspective for Deep Brain Stimulation in Parkinson’s Disease by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use for the Years 2015, 2025 & 2030 |
| INDIA |
| Deep Brain Stimulation in Parkinson’s Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E) |
| India Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson’s Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| India Historic Review for Deep Brain Stimulation in Parkinson’s Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| India 15-Year Perspective for Deep Brain Stimulation in Parkinson’s Disease by Product - Percentage Breakdown of Value Sales for Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation for the Years 2015, 2025 & 2030 |
| India Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson’s Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| India Historic Review for Deep Brain Stimulation in Parkinson’s Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| India 15-Year Perspective for Deep Brain Stimulation in Parkinson’s Disease by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use for the Years 2015, 2025 & 2030 |
| SOUTH KOREA |
| South Korea Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson’s Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| South Korea Historic Review for Deep Brain Stimulation in Parkinson’s Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| South Korea 15-Year Perspective for Deep Brain Stimulation in Parkinson’s Disease by Product - Percentage Breakdown of Value Sales for Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation for the Years 2015, 2025 & 2030 |
| South Korea Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson’s Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| South Korea Historic Review for Deep Brain Stimulation in Parkinson’s Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| South Korea 15-Year Perspective for Deep Brain Stimulation in Parkinson’s Disease by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use for the Years 2015, 2025 & 2030 |
| REST OF ASIA-PACIFIC |
| Rest of Asia-Pacific Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson’s Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Rest of Asia-Pacific Historic Review for Deep Brain Stimulation in Parkinson’s Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Rest of Asia-Pacific 15-Year Perspective for Deep Brain Stimulation in Parkinson’s Disease by Product - Percentage Breakdown of Value Sales for Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation for the Years 2015, 2025 & 2030 |
| Rest of Asia-Pacific Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson’s Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Rest of Asia-Pacific Historic Review for Deep Brain Stimulation in Parkinson’s Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Rest of Asia-Pacific 15-Year Perspective for Deep Brain Stimulation in Parkinson’s Disease by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use for the Years 2015, 2025 & 2030 |
| LATIN AMERICA |
| Deep Brain Stimulation in Parkinson’s Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E) |
| Latin America Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson’s Disease by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR |
| Latin America Historic Review for Deep Brain Stimulation in Parkinson’s Disease by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Latin America 15-Year Perspective for Deep Brain Stimulation in Parkinson’s Disease by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030 |
| Latin America Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson’s Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Latin America Historic Review for Deep Brain Stimulation in Parkinson’s Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Latin America 15-Year Perspective for Deep Brain Stimulation in Parkinson’s Disease by Product - Percentage Breakdown of Value Sales for Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation for the Years 2015, 2025 & 2030 |
| Latin America Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson’s Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Latin America Historic Review for Deep Brain Stimulation in Parkinson’s Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Latin America 15-Year Perspective for Deep Brain Stimulation in Parkinson’s Disease by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use for the Years 2015, 2025 & 2030 |
| ARGENTINA |
| Argentina Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson’s Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Argentina Historic Review for Deep Brain Stimulation in Parkinson’s Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Argentina 15-Year Perspective for Deep Brain Stimulation in Parkinson’s Disease by Product - Percentage Breakdown of Value Sales for Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation for the Years 2015, 2025 & 2030 |
| Argentina Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson’s Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Argentina Historic Review for Deep Brain Stimulation in Parkinson’s Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Argentina 15-Year Perspective for Deep Brain Stimulation in Parkinson’s Disease by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use for the Years 2015, 2025 & 2030 |
| BRAZIL |
| Brazil Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson’s Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Brazil Historic Review for Deep Brain Stimulation in Parkinson’s Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Brazil 15-Year Perspective for Deep Brain Stimulation in Parkinson’s Disease by Product - Percentage Breakdown of Value Sales for Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation for the Years 2015, 2025 & 2030 |
| Brazil Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson’s Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Brazil Historic Review for Deep Brain Stimulation in Parkinson’s Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Brazil 15-Year Perspective for Deep Brain Stimulation in Parkinson’s Disease by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use for the Years 2015, 2025 & 2030 |
| MEXICO |
| Mexico Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson’s Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Mexico Historic Review for Deep Brain Stimulation in Parkinson’s Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Mexico 15-Year Perspective for Deep Brain Stimulation in Parkinson’s Disease by Product - Percentage Breakdown of Value Sales for Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation for the Years 2015, 2025 & 2030 |
| Mexico Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson’s Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Mexico Historic Review for Deep Brain Stimulation in Parkinson’s Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Mexico 15-Year Perspective for Deep Brain Stimulation in Parkinson’s Disease by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use for the Years 2015, 2025 & 2030 |
| REST OF LATIN AMERICA |
| Rest of Latin America Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson’s Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Rest of Latin America Historic Review for Deep Brain Stimulation in Parkinson’s Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Rest of Latin America 15-Year Perspective for Deep Brain Stimulation in Parkinson’s Disease by Product - Percentage Breakdown of Value Sales for Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation for the Years 2015, 2025 & 2030 |
| Rest of Latin America Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson’s Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Rest of Latin America Historic Review for Deep Brain Stimulation in Parkinson’s Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Rest of Latin America 15-Year Perspective for Deep Brain Stimulation in Parkinson’s Disease by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use for the Years 2015, 2025 & 2030 |
| MIDDLE EAST |
| Deep Brain Stimulation in Parkinson’s Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E) |
| Middle East Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson’s Disease by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR |
| Middle East Historic Review for Deep Brain Stimulation in Parkinson’s Disease by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Middle East 15-Year Perspective for Deep Brain Stimulation in Parkinson’s Disease by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030 |
| Middle East Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson’s Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Middle East Historic Review for Deep Brain Stimulation in Parkinson’s Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Middle East 15-Year Perspective for Deep Brain Stimulation in Parkinson’s Disease by Product - Percentage Breakdown of Value Sales for Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation for the Years 2015, 2025 & 2030 |
| Middle East Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson’s Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Middle East Historic Review for Deep Brain Stimulation in Parkinson’s Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Middle East 15-Year Perspective for Deep Brain Stimulation in Parkinson’s Disease by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use for the Years 2015, 2025 & 2030 |
| IRAN |
| Iran Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson’s Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Iran Historic Review for Deep Brain Stimulation in Parkinson’s Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Iran 15-Year Perspective for Deep Brain Stimulation in Parkinson’s Disease by Product - Percentage Breakdown of Value Sales for Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation for the Years 2015, 2025 & 2030 |
| Iran Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson’s Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Iran Historic Review for Deep Brain Stimulation in Parkinson’s Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Iran 15-Year Perspective for Deep Brain Stimulation in Parkinson’s Disease by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use for the Years 2015, 2025 & 2030 |
| ISRAEL |
| Israel Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson’s Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Israel Historic Review for Deep Brain Stimulation in Parkinson’s Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Israel 15-Year Perspective for Deep Brain Stimulation in Parkinson’s Disease by Product - Percentage Breakdown of Value Sales for Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation for the Years 2015, 2025 & 2030 |
| Israel Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson’s Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Israel Historic Review for Deep Brain Stimulation in Parkinson’s Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Israel 15-Year Perspective for Deep Brain Stimulation in Parkinson’s Disease by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use for the Years 2015, 2025 & 2030 |
| SAUDI ARABIA |
| Saudi Arabia Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson’s Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Saudi Arabia Historic Review for Deep Brain Stimulation in Parkinson’s Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Saudi Arabia 15-Year Perspective for Deep Brain Stimulation in Parkinson’s Disease by Product - Percentage Breakdown of Value Sales for Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation for the Years 2015, 2025 & 2030 |
| Saudi Arabia Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson’s Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Saudi Arabia Historic Review for Deep Brain Stimulation in Parkinson’s Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Saudi Arabia 15-Year Perspective for Deep Brain Stimulation in Parkinson’s Disease by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use for the Years 2015, 2025 & 2030 |
| UNITED ARAB EMIRATES |
| UAE Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson’s Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| UAE Historic Review for Deep Brain Stimulation in Parkinson’s Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| UAE 15-Year Perspective for Deep Brain Stimulation in Parkinson’s Disease by Product - Percentage Breakdown of Value Sales for Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation for the Years 2015, 2025 & 2030 |
| UAE Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson’s Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| UAE Historic Review for Deep Brain Stimulation in Parkinson’s Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| UAE 15-Year Perspective for Deep Brain Stimulation in Parkinson’s Disease by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use for the Years 2015, 2025 & 2030 |
| REST OF MIDDLE EAST |
| Rest of Middle East Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson’s Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Rest of Middle East Historic Review for Deep Brain Stimulation in Parkinson’s Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Rest of Middle East 15-Year Perspective for Deep Brain Stimulation in Parkinson’s Disease by Product - Percentage Breakdown of Value Sales for Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation for the Years 2015, 2025 & 2030 |
| Rest of Middle East Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson’s Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Rest of Middle East Historic Review for Deep Brain Stimulation in Parkinson’s Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Rest of Middle East 15-Year Perspective for Deep Brain Stimulation in Parkinson’s Disease by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use for the Years 2015, 2025 & 2030 |
| AFRICA |
| Deep Brain Stimulation in Parkinson’s Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E) |
| Africa Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson’s Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Africa Historic Review for Deep Brain Stimulation in Parkinson’s Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Africa 15-Year Perspective for Deep Brain Stimulation in Parkinson’s Disease by Product - Percentage Breakdown of Value Sales for Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation for the Years 2015, 2025 & 2030 |
| Africa Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson’s Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Africa Historic Review for Deep Brain Stimulation in Parkinson’s Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Africa 15-Year Perspective for Deep Brain Stimulation in Parkinson’s Disease by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use for the Years 2015, 2025 & 2030 |
COMPETITIVE METRICS
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: [email protected]